Bio-Pharmaceutical Subsidiary Approved to Produce South African Type 1 Multivalent Foot-and-Mouth Disease Vaccine

证券时报··Read original
2▲1 ▼0Impact / 5
Summary · why it matters

Bio-Pharmaceutical announced that its subsidiary, Jinyu Baoling Biological Pharmaceutical Co., Ltd., has been approved by the Ministry of Agriculture and Rural Affairs to produce a trivalent inactivated vaccine for cattle and sheep against foot-and-mouth disease types O, A, and South African type 1, as well as a bivalent inactivated vaccine for pigs against foot-and-mouth disease types O and South African type 1, and has obtained the veterinary drug product approval number.

Impact on assets 1

Others▲ · 1 stocks
Jinyu Bio-Technology Co Ltd
600201
▲ PositiveRegulationrelevance

Subsidiary Jinyu Baoling received approval from Ministry of Agriculture to produce new foot-and-mouth disease vaccines, expanding product portfolio.

Off-coverage companies 1

金宇保灵生物药品有限公司Private▲ Positive
Regulationrelevance

Jinyu Baoling obtained veterinary drug product approval numbers for new vaccines, enabling production and sales.

© 2026 MarketIVNews